Physician profile
Frank Lamarca
NPI 1548367808
$4,834,315.59
in general payments reported to CMS, 2019-2025
14 companies · $1.1M in 2025
The $1.1M reported for 2025 was more than what 99% of Neurological Surgery providers received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $666K · 2020: $524K · 2021: $605K · 2022: $681K · 2023: $665K · 2024: $560K · 2025: $1.1M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.2M · Consulting Fee: $138K · Travel and Lodging: $8,831 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,250 · Food and Beverage: $871 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,207,479.18 |
| Consulting Fee | $138,422.33 |
| Travel and Lodging | $8,831.33 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,250.00 |
| Food and Beverage | $870.51 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $4,435,953.03 | 2019-2025 | Creo, Quartex, Creo Threaded 4.75 Cocr |
| Medical Device Business Services, INC. | $125,104.30 | 2019-2022 | |
| Stryker Corporation | $79,692.86 | 2019-2024 | Cascadia Interbody System |
| Zimmer Biomet Holdings, INC. | $60,807.18 | 2019-2022 | |
| Expanding Innovations, INC. | $47,322.60 | 2021-2025 | X-Pac |
| Depuy Synthes Products, INC. | $45,987.84 | 2019-2025 | Conduit |
| Bioventus LLC | $12,696.01 | 2019-2021 | |
| Kuros Biosciences USA, INC | $11,555.99 | 2022-2024 | Magnetos |
| Zimvie INC. | $9,711.19 | 2022-2023 | |
| Highridge Medical LLC | $4,334.27 | 2024-2025 | Zyston Strut, Zyston Curve Spacer |
| Depuy Synthes Sales INC. | $759.91 | 2019-2023 | Teligen |
| Integrity Implants INC. | $260.69 | 2021 | |
| Si-Bone, INC. | $109.72 | 2022 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$169,512.70 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Lamarca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.